Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Endometrial Stromal Sarcoma

Endometrial Stromal Sarcoma Uterine sarcomas comprise 2–3% of all uterine malignancies. Tumors in this category are, in order of decreasing incidence, carcinosarcoma, leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. Endometrial stromal sarcomas are divided into low- and high-grade according to tumor cell morphology and mitotic rate. Low-grade tumors are characterized by a slow growth pattern, presence of estrogen and/or progesterone receptors, and an indolent clinical course with late recurrences. Despite this indolent course, 37–60% of patients with early-stage disease experience recurrent disease. High-grade stromal sarcomas, on the other hand, exhibit more aggressive biological behavior and poor outcome. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Endometrial Stromal Sarcoma

Download PDF
11 pages

Loading next page...
 
/lp/springer-journals/endometrial-stromal-sarcoma-NBE90jcgUe
Publisher
Springer Journals
Copyright
Copyright © 2004 by Adis Data Information BV
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200403010-00002
Publisher site
See Article on Publisher Site

Abstract

Uterine sarcomas comprise 2–3% of all uterine malignancies. Tumors in this category are, in order of decreasing incidence, carcinosarcoma, leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. Endometrial stromal sarcomas are divided into low- and high-grade according to tumor cell morphology and mitotic rate. Low-grade tumors are characterized by a slow growth pattern, presence of estrogen and/or progesterone receptors, and an indolent clinical course with late recurrences. Despite this indolent course, 37–60% of patients with early-stage disease experience recurrent disease. High-grade stromal sarcomas, on the other hand, exhibit more aggressive biological behavior and poor outcome.

Journal

American Journal of Cancer – Springer Journals

Published: Aug 10, 2012

References

  • Retrospective analysis of 318 cases of uterine sarcoma
    Oláh, K.S.; Gee, H.; Blunt, S.
  • Sarcomas of the uterus: a clinicopathologic study of 119 patients
    Kahanpaa, K.V.; Wahlstrom, T.; Grohn, P.
  • Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas
    Leibsohn, S.; d’Ablaing, G.; Mishell, D.R.
  • MR imaging findings of uterine endometrial stromal sarcoma: differentiation from endometrial carcinoma
    Ueda, M.; Otsuka, M.; Hatakenaka, M.
  • Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging
    Umesaki, N.; Tanaka, T.; Miyama, M.
  • An immunohistochemical study of normal endometrial stroma and endometrial neoplasms: evidence for smooth muscle differentiation
    Franquemont, D.W.; Frierson, H.F.; Mills, S.E.
  • Myogenous phenotype of epithelial-like areas in endometrial stromal sarcomas
    Lillemoe, T.J.; Perrone, T.; Norris, H.J.
  • Immunohistochemistry of endometrial stromal sarcoma
    Farhood, A.I.; Abrams, J.
  • Endometrial stromal sarcoma: immunohistochemical, electron microscopical and cytogenetic findings in two cases
    Gil-Benso, R.; Lopez-Gines, C.; Carda, C.
  • Antisera to acute lymphoblastic leukemia cells
    Greaves, M.F.; Brown, G.; Rapson, N.T.
  • The common acute lymphoblastic leukemia antigen (CD10): emancipation from a functional enigma
    Bien, T.W.; McCormack, R.T.
  • CD 10: a review
    Arber, D.A.; Weiss, L.M.
  • Cell surface peptides in human endometrium
    Imai, K.; Kanzaki, H.; Mori, T.
  • Human endometrial stromal cells express cluster of differentiation (CD) 13 antigen/aminopeptidase N and CD1O antigen/ neutral endopeptidase
    Imai, K.; Maeda, M.; Fujiwara, H.
  • Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases
    Chu, P.G.; Arber, D.A.; Weiss, L.M.
  • CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms
    McCluggage, W.G.; Sumathi, V.P.; Maxwell, P.
  • h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors
    Nucci, M.R.; O’Connell, J.T.; Huettner, P.C.
  • Endometrial carcinoma: causes of death and sites of treatment failure
    Yoonessi, M.; Anderson, D.G.; Morley, G.W.
  • Endometrial stroma sarcoma
    Henriksen, H.M.; Hornboll, P.
  • Uterine endolymphatic stromal myosis: a collaborative study
    Piver, M.S.; Rutledge, F.N.; Copeland, L.
  • Endometrial stromal sarcoma: a report of nine cases
    Taina, E.; Maenpaa, J.; Erkkola, R.
  • Treatment of endometrial stromal tumors
    Berchuck, A.; Rubin, S.C.; Hoskins, W.J.
  • Mesenchymal tumors of the uterus: I. a clinical and pathological study of 53 endometrial stromal tumors
    Norris, H.J.; Taylor, H.B.
  • Uterine sarcomas: classification, diagnosis, and prognosis
    Kempson, R.L.; Bari, W.
  • Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945–1980
    Fusco, P.A.; Gaffey, T.A.; Malkasian, G.D.
  • Endometrial stromal sarcoma and poorly differentiated endometrial sarcoma
    Evans, H.L.
  • Primary uterine endometrial stromal neoplasms: a clinicopathologic study of 117 cases
    Chang, K.L.; Crabtree, G.S.; Lim-Tan, S.K.
  • An excess of uterine sarcomas after pelvic irradiation
    Meredith, R.F.; Eisert, D.R.; Kaka, Z.
  • Uterine sarcoma and tamoxifen: poor prognosis compared to endometrial adenocarcinoma [abstract 161]
    Honig, S.F.; Wysowski, D.K.; Beitz, J.
  • Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma
    Pautier, P.; Genestie, C.; Rey, A.
  • Neoplasms of endometrial stroma: histopathologic and flow cytometric analysis with clinical correlation
    August, C.Z.; Bauer, K.D.; Lurain, J.
  • Low-grade stromal sarcoma: DNAflow cytometric analysis and estrogen progesterone receptor data
    Dunton, C.J.; Kelsten, M.L.; Brooks, S.E.
  • Nuclear DNA content in endolymphatic stromal myosis
    Goldfarb, S.; Richart, R.M.; Okagaki, T.
  • The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma
    Nordal, R.R.; Kristensen, G.B.; Kaern, J.
  • Uterine stromatosis: clinicopathologic features and hormone dependency
    Baggish, M.S.; Woodruff, J.D.
  • Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace
    Scribner, D.R.; Walker, J.L.
  • Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence
    Goff, B.A.; Rice, L.W.; Fleischhacker, D.
  • Low-grade endometrial stromal sarcoma with cardiovascular involvement: a report of three cases
    Tabata, T.; Takeshima, N.; Hirai, Y.
  • Endolymphatic stromal myosis: report of a case treated surgically and with hormones
    Jacobsen, K.B.; Haram, K.
  • Endometrial stromal sarcomas
    Mansi, J.L.; Ramachandra, S.; Wiltshaw, E.
  • Recurrent endometrial stromal sarcoma resembling intravenous leiomyomatosis
    Whitlatch, S.P.; Meyer, R.L.
  • Endolymphatic stromal myosis; surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy
    Gloor, E.; Schnyder, P.; Cikes, M.
  • Low-grade endometrial stromal sarcoma recurring over three decades
    Styron, S.L.; Burke, T.W.; Linville, W.K.
  • Adjuvant therapy for stage I uterine sarcoma
    Rose, P.G.; Boutselis, J.G.; Sachs, L.
  • Treatment of uterine sarcomas
    Echt, G.; Jepson, J.; Steel, J.
  • Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestogen receptor levels in three tumors
    Katz, L.; Merino, M.J.; Sakamoto, H.
  • Steroid hormone receptors in endometrial stromal sarcomas: a biochemical and immunohistochemical study
    Sabini, G.; Chumas, J.C.; Mann, W.J.
  • Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas
    Reich, O.; Regauer, S.; Urdl, W.
  • Endolymphatic stromal myosis: a case with positive estrogen and progesterone receptors and good response to progestogens
    Tsukamoto, N.; Kamura, T.; Matsukuma, K.
  • Estrogen and progesterone receptors in uterine sarcomas
    Sutton, G.P.; Stehman, F.B.; Michael, H.
  • Proliferative stromatosis of the uterus with pulmonary metastases: remission following treatment with a long acting synthetic progestogen: a case report
    Pellillo, D.
  • Endolymphatic stromal myosis with pulmonary metastases: remission with progestogen therapy: report of a case
    Krumholz, B.A.; Lobovsky, F.Y.; Halitsky, V.
  • Progestogen-induced regression in low-grade endometrial stromal sarcoma: case report and literature review
    Keen, C.E.; Philip, G.
  • Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence
    Montag, T.W.; Manart, F.D.
  • Low-grade endometrial stromal sarcoma treated with a progestogen
    Rand, R.J.; Lowe, J.W.
  • Estradiol and progesterone receptors in two cases of endometrial stromal sarcoma
    Lantta, M.; Kahanpaa, K.; Karkkainen, J.
  • Aggressive endometrial stromal sarcoma responding to medroxyprogesterone following failure of tamoxifen and combination chemotherapy: case report
    O’Brien, A.A.; O’Briain, D.S.; Daly, P.A.
  • Effects of leuprolide acetate on low-grade endometrial stromal sarcoma
    Mesia, A.F.; Demopoulos, R.I.
  • Endometrial stromal sarcoma: objective response to letrozole
    Maluf, F.C.; Sabbatini, P.; Schwartz, L.
  • Uterine stromatosis: a report of 33 cases
    Thatcher, S.S.; Woodruff, J.D.
  • Adriamycin and bleomycin, alone and in combination, in gynecologic cancers
    Barlow, J.J.; Piver, M.S.; Chuang, J.T.
  • Treatment of stage IV “high-grade” endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin
    Yamawaki, T.; Shimizu, Y.; Hasumi, K.
  • Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group
    Sutton, G.; Blessing, J.A.; Park, R.
  • A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas
    Omura, G.A.; Major, F.J.; Blessing, J.A.
  • Treatment of recurrent or advanced uterine sarcoma: a randomized trial of doxombicin versus doxorubicin and cyclophos-phamide (a phase III trial of the Gynecologic Oncology Group)
    Muss, H.B.; Bundy, B.; DiSaia, P.J.
  • Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract
    Piver, M.S.; DeEulis, T.G.; Lele, S.B.
  • Response of endometrial stromal sarcoma to cyclophosphamide
    Hoovis, M.L.
  • Prolonged stabilization of progressive endometrial stromal sarcoma with prolonged oral etoposide therapy
    Lin, Y.C.; Kudelka, A.P.; Tresukosol, D.
  • Endometrioid sarcoma (“stromal endometriosis”): report of 15 cases including 5 with metastases
    Jensen, P.A.; Dockerty, M.B.; Symmonds, R.E.
  • Endometrial stromatosis of the uterus
    Hart, W.R.; Yoonessi, M.
  • Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel
    Szlosarek, P.W.; Lofts, F.J.; Pettengell, R.
  • Chemotherapy for advanced sarcoma: therapeutic decisions and modalities
    Keohan, M.L.; Taub, R.N.
  • Anthracyclines in the treatment of gynecologic malignancies
    Maluf, F.C.; Spriggs, D.
  • A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study
    Omura, G.A.; Blessing, J.A.; Major, F.
  • Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial
    Frustaci, S.; Gherlinzoni, F.; Paoli, A.
  • Complete remission of widely metastatic endometrial stromal sarcoma following combination chemotherapy
    Lehrner, L.M.; Miles, P.A.; Enck, R.E.